AbbVie Chooses Cerebras Systems to Accelerate AI Biopharmaceutical Research

SUNNYVALE, Calif.--(BUSINESS WIRE)--Cerebras Systems, the pioneer in high performance artificial intelligence (AI) computing, and AbbVie, a global biopharmaceutical company, today announced a landmark achievement in AbbVie’s AI work. Using a Cerebras CS-2 on biomedical natural language processing (NLP) models, AbbVie achieved performance in excess of 128 times that of a...

Click to view original post